RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 107 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $3,000 | 0.0% | 251 | 0.0% | 0.00% | – |
Q4 2021 | $3,000 | 0.0% | 251 | 0.0% | 0.00% | – |
Q3 2021 | $3,000 | -40.0% | 251 | 0.0% | 0.00% | – |
Q2 2021 | $5,000 | 0.0% | 251 | 0.0% | 0.00% | – |
Q1 2021 | $5,000 | -99.7% | 251 | -99.7% | 0.00% | -100.0% |
Q2 2020 | $1,926,000 | +217.3% | 86,359 | +116.7% | 0.01% | +200.0% |
Q1 2020 | $607,000 | – | 39,859 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 909,258 | $10,475,000 | 3.58% |
NEA Management Company, LLC | 4,912,306 | $56,590,000 | 1.64% |
RA Capital Management | 4,871,067 | $56,115,000 | 1.22% |
Pinz Capital Management, LP | 148,475 | $1,710,000 | 1.07% |
Samsara BioCapital, LLC | 345,293 | $3,978,000 | 1.00% |
Bell & Brown Wealth Advisors, LLC | 117,400 | $1,352,000 | 0.61% |
Rock Springs Capital Management LP | 1,237,026 | $14,251,000 | 0.36% |
ACT CAPITAL MANAGEMENT, LLC | 27,500 | $317,000 | 0.34% |
Endurant Capital Management LP | 105,792 | $1,219,000 | 0.32% |
Baker Brothers Advisors | 4,125,062 | $47,521,000 | 0.27% |